Download Amyloid Proteins: Methods and Protocols by Gal Bitan, David B. Teplow (auth.), Einar M. Sigurdsson PDF

By Gal Bitan, David B. Teplow (auth.), Einar M. Sigurdsson (eds.)

A confirmed selection of conveniently reproducible recommendations for learning amyloid proteins and their involvement within the etiology, pathogenesis, prognosis, and treatment of amyloid illnesses. The individuals supply tools for the guidance of amyloid and its precursors (oligomers and protofibrils), in vitro assays and analytical ideas for his or her examine, and phone tradition versions and assays for the construction of amyloid proteins. extra chapters current comfortably reproducible concepts for amyloid extraction from tissue, its detection in vitro and in vivo, in addition to nontransgenic tools for constructing amyloid mouse versions. The protocols stick to the winning tools in Molecular Biology™ sequence layout, every one providing step by step laboratory directions, an creation outlining the main at the back of the procedure, lists of the mandatory apparatus and reagents, and pointers on troubleshooting and warding off recognized pitfalls.

Show description

Read or Download Amyloid Proteins: Methods and Protocols PDF

Similar biotechnology books

Application of Solution Protein Chemistry to Biotechnology (Protein Science)

Reflecting the flexibility of the author’s technological know-how and the intensity of his event, program of resolution Protein Chemistry to Biotechnology explores key contributions that protein scientists could make within the improvement of goods which are either vital and commercially doable, and offers them with instruments and knowledge required for winning participation.

Pharmacokinetics and Pharmacodynamics of Biotech Drugs: Principles and Case Studies in Drug Development

This primary ever insurance of the pharmacokinetic and pharmacodynamic features of biopharmaceuticals meets the necessity for a accomplished ebook during this box. It spans all subject matters from lead identity correct as much as final-stage medical trials. Following an advent to the position of PK and PD within the improvement of biotech medicinal drugs, the publication is going directly to conceal the fundamentals, together with the pharmacokinetics of peptides, monoclonal antibodies, antisense oligonucleotides, in addition to viral and non-viral gene supply vectors.

Protein Engineering. Approaches to the Manipulation of Protein Folding

This e-book addresses the theoretical implication of the protein challenge and descriptions new genetic instruments to synthesize gene coding for novel proteins, site-directed mutagenesis, gene transposition, and phenotype choice technique. moreover, it describes quite a few physiochemical instruments corresponding to x-ray crystallography and protein spectroscopy to review protein constitution.

Additional resources for Amyloid Proteins: Methods and Protocols

Example text

Curr. Neurol. Neurosci. Rep. 1(5), 451–457. Lichtenthaler, S. , et al. (1997) Mutations in the transmembrane domain of APP altering gamma-secretase specificity. Biochemistry 36(49), 15396–15403. , et al. (2000) A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer’s disease. Nature 408(6815), 979–982. , et al. (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer’s disease. Nature 408(6815), 982–985. , et al. (2001) The ‘Arctic’ APP mutation (E693G) causes Alzheimer’s disease by enhanced Abeta protofibril formation.

Purified AbARC protofibrils formed in the presence of WT are stable for 1 to 4 d at 4°C (as judged by SEC and EM) (12), providing sufficient time to study and characterize these intermediates. Therefore, a 1:1 mixture of AbARC and AbWT (100 µM) is used to prepare annular protofibrils of AbARC (Fig. 2). Attempts to separate Ab protofibrils prepared from Ab40 or Ab40ARC alone on superose 6 have failed, as the protofibrils have been observed to interact with the column matrix and/or undergo dissociation to monomers.

Some peptides from the tau sequence can adopt a-helical conformation, but only in non-physiological buffers including helix-inducing agents (12–15). Earlier studies on tau in PHFs using X-ray fiber diagrams of NFTs or reassembled tau fibers show only weak or no contributions from b-structure (11,16). Additionally, neurofibrillary tangles and tau fibers stain poorly with Congo red, a dye considered indicative of cross-b-structure, compared with thioflavin-S Purification of Tau 37 (17). Only recently, it was shown that upon polymerization of tau to PHFs a shift from a random coil structure to an increased b-structure content occurs (18–22).

Download PDF sample

Rated 4.17 of 5 – based on 24 votes